GSK2248761

DRUG6 trials

Sponsors

GlaxoSmithKline, ViiV Healthcare

Conditions

HIV InfectionsHealthy SubjectsInfection, Human Immunodeficiency VirusInfection, Human Immunodeficiency Virus I

Phase 1

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

CompletedNCT00920088

GlaxoSmithKlineHealthy Subjects, Infection, Human Immunodeficiency Virus

Start: 2009-06-30End: 2009-11-30Updated: 2010-11-03

A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects

CompletedNCT01101893

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2010-04-30End: 2010-06-30Updated: 2017-09-11

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

CompletedNCT01138072

GlaxoSmithKlineInfection, Human Immunodeficiency Virus

Start: 2010-06-30End: 2010-08-31Updated: 2010-11-05

A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

TerminatedNCT01195974

ViiV HealthcareHIV Infections, Infection, Human Immunodeficiency Virus

Start: 2010-09-14End: 2011-02-09Updated: 2019-02-20

A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.

WithdrawnNCT01283100

ViiV HealthcareInfection, Human Immunodeficiency Virus I

Start: 2011-03-31End: 2011-06-30Updated: 2014-12-24

Phase 2

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

CompletedNCT00945282

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2009-10-20End: 2009-11-28Updated: 2018-11-29